EMPIRE STATE REALTY TRUST-A (ESRT) Fundamental Analysis & Valuation

NYSE:ESRT • US2921041065

Current stock price

5.2 USD
+0.1 (+1.96%)
At close:
5.2 USD
0 (0%)
After Hours:

This ESRT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ESRT Profitability Analysis

1.1 Basic Checks

  • In the past year ESRT was profitable.
  • ESRT had a positive operating cash flow in the past year.
  • Of the past 5 years ESRT 4 years were profitable.
  • In the past 5 years ESRT always reported a positive cash flow from operatings.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • ESRT has a Return On Assets (0.97%) which is in line with its industry peers.
  • ESRT has a Return On Equity of 3.98%. This is in the better half of the industry: ESRT outperforms 60.66% of its industry peers.
  • ESRT has a Return On Invested Capital (2.50%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ESRT is in line with the industry average of 3.11%.
Industry RankSector Rank
ROA 0.97%
ROE 3.98%
ROIC 2.5%
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)4.43%
ROE(5y)3.19%
ROIC(3y)2.75%
ROIC(5y)2.48%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.65%, ESRT is in line with its industry, outperforming 55.74% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ESRT has grown nicely.
  • With a Operating Margin value of 17.66%, ESRT perfoms like the industry average, outperforming 42.62% of the companies in the same industry.
  • ESRT's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ESRT (53.70%) is worse than 75.41% of its industry peers.
  • In the last couple of years the Gross Margin of ESRT has remained more or less at the same level.
Industry RankSector Rank
OM 17.66%
PM (TTM) 5.65%
GM 53.7%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ESRT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ESRT is destroying value.
  • The number of shares outstanding for ESRT has been increased compared to 1 year ago.
  • ESRT has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ESRT has been reduced compared to a year ago.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.48, we must say that ESRT is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.48, ESRT perfoms like the industry average, outperforming 54.10% of the companies in the same industry.
  • ESRT has a Debt/Equity ratio of 2.18. This is a high value indicating a heavy dependency on external financing.
  • ESRT has a Debt to Equity ratio of 2.18. This is in the lower half of the industry: ESRT underperforms 70.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACC0.44
WACC5.73%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ESRT has a Current Ratio of 2.34. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • ESRT's Current ratio of 2.34 is amongst the best of the industry. ESRT outperforms 90.98% of its industry peers.
  • ESRT has a Quick Ratio of 2.34. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.34, ESRT belongs to the top of the industry, outperforming 90.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.34
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ESRT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.10% over the past year.
  • The Earnings Per Share has been growing by 57.42% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 0.05% in the past year.
  • Measured over the past years, ESRT shows a small growth in Revenue. The Revenue has been growing by 4.75% on average per year.
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%

3.2 Future

  • The Earnings Per Share is expected to decrease by -39.35% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 2.24% on average over the next years.
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. ESRT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.98, which indicates a rather cheap valuation of ESRT.
  • 99.18% of the companies in the same industry are more expensive than ESRT, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.35. ESRT is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 84.97, ESRT can be considered very expensive at the moment.
  • ESRT's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.61. ESRT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 5.98
Fwd PE 84.97
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ESRT is valued cheaper than 86.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.47
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • ESRT's earnings are expected to decrease with -61.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. ESRT Dividend Analysis

5.1 Amount

  • ESRT has a Yearly Dividend Yield of 2.82%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 7.54, ESRT's dividend is way lower than its industry peers. On top of this 81.15% of the companies listed in the same industry pay a better dividend than ESRT!
  • Compared to an average S&P500 Dividend Yield of 1.89, ESRT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.82%

5.2 History

  • The dividend of ESRT decreases each year by -6.73%.
  • ESRT has paid a dividend for at least 10 years, which is a reliable track record.
  • ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-6.73%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • ESRT pays out 64.35% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of ESRT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP64.35%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ESRT Fundamentals: All Metrics, Ratios and Statistics

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (3/31/2026, 8:04:00 PM)

After market: 5.2 0 (0%)

5.2

+0.1 (+1.96%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17
Earnings (Next)04-27
Inst Owners103.01%
Inst Owner Change1.34%
Ins Owners0.08%
Ins Owner Change0.04%
Market Cap890.45M
Revenue(TTM)768.27M
Net Income(TTM)43.40M
Analysts75
Price Target7.41 (42.5%)
Short Float %5.79%
Short Ratio5.85
Dividend
Industry RankSector Rank
Dividend Yield 2.82%
Yearly Dividend0.17
Dividend Growth(5Y)-6.73%
DP64.35%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-13
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.36%
PT rev (3m)-15.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.98
Fwd PE 84.97
P/S 1.16
P/FCF N/A
P/OCF 3.58
P/B 0.82
P/tB 3.04
EV/EBITDA 9.47
EPS(TTM)0.87
EY16.73%
EPS(NY)0.06
Fwd EY1.18%
FCF(TTM)-2.11
FCFYN/A
OCF(TTM)1.45
OCFY27.97%
SpS4.49
BVpS6.36
TBVpS1.71
PEG (NY)N/A
PEG (5Y)0.1
Graham Number11.16
Profitability
Industry RankSector Rank
ROA 0.97%
ROE 3.98%
ROCE 3.16%
ROIC 2.5%
ROICexc 2.58%
ROICexgc 3.19%
OM 17.66%
PM (TTM) 5.65%
GM 53.7%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)4.43%
ROE(5y)3.19%
ROIC(3y)2.75%
ROIC(5y)2.48%
ROICexc(3y)2.96%
ROICexc(5y)2.68%
ROICexgc(3y)3.73%
ROICexgc(5y)3.4%
ROCE(3y)3.48%
ROCE(5y)3.14%
ROICexgc growth 3Y-2.22%
ROICexgc growth 5Y10.35%
ROICexc growth 3Y-1.13%
ROICexc growth 5Y11.75%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF N/A
Debt/EBITDA 7.18
Cap/Depr 313.47%
Cap/Sales 79.47%
Interest Coverage 1.45
Cash Conversion 75.38%
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 2.34
Altman-Z 0.48
F-Score6
WACC5.73%
ROIC/WACC0.44
Cap/Depr(3y)200.4%
Cap/Depr(5y)163.62%
Cap/Sales(3y)50.04%
Cap/Sales(5y)43.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%
EBIT growth 1Y-14.53%
EBIT growth 3Y2.22%
EBIT growth 5Y15.89%
EBIT Next Year144.54%
EBIT Next 3Y36.3%
EBIT Next 5Y22.27%
FCF growth 1Y-231.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.54%
OCF growth 3Y5.65%
OCF growth 5Y6.44%

EMPIRE STATE REALTY TRUST-A / ESRT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


Can you provide the valuation status for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


Can you provide the profitability details for EMPIRE STATE REALTY TRUST-A?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for ESRT stock?

The Earnings per Share (EPS) of EMPIRE STATE REALTY TRUST-A (ESRT) is expected to decline by -92.97% in the next year.


How sustainable is the dividend of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The dividend rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 3 / 10 and the dividend payout ratio is 64.35%.